Renal Disease Market Overview
The renal disease market is projected to reach USD89,070 Million by 2030 at 11.20% CAGR during the forecast period 2022-2030.Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Global Renal disease Market is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market. With the number of kidney failure patients expected to continue to rise in the future, healthcare providers are seeking new ways to expand treatment options, improve outcomes, and reduce the chronic health conditions that contribute to the potentially deadly disease.
The rising prevalence of kidney diseases, diabetes, hypertension and rapid growth in the geriatric population have led to the growth of the global renal disease market in recent years. However, rising healthcare costs and stringent regulatory policies are likely to restrain market growth over the forecast period.
Segmentation
A comprehensive segmental analysis of the Global Renal Disease Market is available in MRFR’s report. The segment analysis covers disease types, treatment types, and end uses.
By disease type, the market has been segmented into end-stage renal diseases (ESRD) and chronic kidney disease. The chronic kidney disease segment holds a significant share of the market in terms of revenue. In 2017, the segment commanded more than USD 60,200 Mn and is expected to highly attractive during the forecast period. By treatment type, the market has been segmented into kidney transplantation, medication, and dialysis. Based on end user, the market has been segmented into research and academic institutes, hospitals & clinics, and dialysis centers.
Regional Analysis
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
A vague statistic indicates that 30 million American adults are likely to have chronic kidney disease and most aren't aware of it. 1 in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history of kidney failure. People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease. African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end stage renal disease.
Renal Disease Market Players
- Company (US)
- Hoffmann- La Roche Ltd (Switzerland)
- Fresenius Medical Care AG & Co., Ltd (Japan)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Sanofi SA (France) and
- Teva Pharmaceutical Industries Ltd (Israel)
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/renal-disease-market-3167
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Renal Disease Market: Information by Disease Type (Chronic Kidney Disease and End-Stage Renal Disease (ESRD)), by Treatment Type (Dialysis, Medication and Kidney Transplantation), by End User (Dialysis Centers, Hospital & Clinics, and Research and Academic Institutes) and by Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027The global renal diseases market has been growing at an incremental pace and is expected to attain USD 14291.2 Mn by the end of 2023, reveals Market Research Future (MRFR) in a minutely analyzed research report.
These factors in conjunction will shape the global renal disease market and help it achieve a CAGR of 6.3% over the forecast period of 2017-2023.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/3167 SegmentationThe global renal disease market has been segmented based on type, diagnosis, and treatment.
By diagnosis, the market has been segmented into Blood tests, Urine tests, imaging tests, removing a sample of kidney tissue for testing, and others.
The blood tests segment has been further segmented into Serum Creatinine, Glomerular Filtration Rate (GFR), Blood Urea Nitrogen (BUN), and fasting blood glucose test.
The urine test segment has been further segmented into Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test.
The medication segment has been further segmented into High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, and Medications to protect your bones.
